Showing results (61-70 of 96) with videos related to
Sort By:
Pageof 10
Journal of Intensive Care|December 30, 2022
Timing of tracheostomy and patient outcomes in critically ill patients requiring extracorporeal membrane oxygenation: a single-center retrospective observational studyRyota Nukiwa, Akinori Uchiyama, Aiko Tanaka, et al.British Journal of Haematology|April 4, 2019
Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndromeYoshimitsu Shimomura, Masahiko Hara, Takayoshi Tachibana, et al.Nano Letters|March 16, 2026
Balancing Multivalent Avidity and Receptor Availability Governs mRNA Delivery by Antibody-Functionalized Lipid NanoparticlesKazuki Hashiba, Masahiro Fukasaka, Chisa Okuma, et al.British Journal of Haematology|July 25, 2024
Reduced-intensity conditioning with fludarabine/busulfan versus fludarabine/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantationKimimori Kamijo, Yoshimitsu Shimomura, Sung-Won Kim, et al.Journal of Gastroenterology|June 17, 2023
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas SocietyYoshito Tomimaru, Hidetoshi Eguchi, Yoshimitsu Shimomura, et al.Bone Marrow Transplantation|September 7, 2021
Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysisShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.Bone Marrow Transplantation|April 4, 2025
Improved post-transplant outcomes for elderly acute myeloid leukemia patients conditioned with FLU/BU4 rather than conventional MAC regimensTakuya Shimizu, Yasuyuki Arai, Tadakazu Kondo, et al.International Journal of Hematology|May 20, 2025
Impact of center volume on acute graft versus host disease in allogeneic stem cell transplant recipientsYoshimitsu Shimomura, Seitaro Terakura, Keitaro Matsuo, et al.Transplantation and Cellular Therapy|January 13, 2024
Impact of Center Volume on Chronic Graft Versus Host Disease in Patients With Allogeneic Stem Cell TransplantationYoshimitsu Shimomura, Tetsuhisa Kitamura, Makoto Murata, et al.Transplantation and Cellular Therapy|March 17, 2022
Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched AnalysisShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.Pageof 10